CTCBIO Inc. (KOSDAQ: 060590)
South Korea
· Delayed Price · Currency is KRW
6,320.00
-260.00 (-3.95%)
Dec 20, 2024, 9:00 AM KST
CTCBIO Revenue
CTCBIO had revenue of 35.79B KRW in the quarter ending September 30, 2024, with 14.76% growth. This brings the company's revenue in the last twelve months to 138.95B, up 0.53% year-over-year. In the year 2023, CTCBIO had annual revenue of 137.88B, down -16.54%.
Revenue (ttm)
138.95B
Revenue Growth
+0.53%
P/S Ratio
1.09
Revenue / Employee
558.03M
Employees
249
Market Cap
151.10B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 137.88B | -27.33B | -16.54% |
Dec 31, 2022 | 165.21B | 24.89B | 17.74% |
Dec 31, 2021 | 140.32B | 10.29B | 7.91% |
Dec 31, 2020 | 130.03B | -6.09B | -4.48% |
Dec 31, 2019 | 136.12B | -2.28B | -1.64% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition